In Part 1 about change facing FDA, we looked at the 21st Century Cures Act and some of the change that would be in store for FDA. But in this post-election cycle, there is more than pending legislation that could … Continue reading ...
PM360 magazine is asking its readers find marketing campaigns and tactics used by consumer packaged goods, retail, and other industries to give pharma marketers some fresh ideas. Here's what one ad agency SVP Executive Creative Director...Show More Summary
About 22 weeks ago, Emily Maynard Johnson, who appeared on ABC's The Bachelor and The Bachelorette, posted the following Diclegis promotion to her Instagram account: I assume you've noticed that all the ISI (Important Safety Information)...Show More Summary
Well, CVS Health blinked. In July 2017, CVS Health’s retail pharmacies will become a preferred retail channel for 90-day prescriptions dispensed to OptumRx’s commercial clients. Here’s the press release: OptumRx and CVS Pharmacy Partner...Show More Summary
One of the often stated priorities for lame-duck Congress has been voting on the 21st Century Cures Act. In a press release from Saturday, November 26 from the House Energy and Commerce Committee, the House is set to vote on … Continue reading ?
Hope everyone enjoyed the Thanksgiving holiday! Now that you’ve stretched your stomach, stretch your mind with some food for thought. In this issue: Dispensing oncology practices win their battle with PBM CVS Caremark 2016 was a record...Show More Summary
Expanded Access Programs 2017March 9-10, 2017 | Washington, DCThe evolving political landscape is transforming and expanding patient access to experimental and unapproved drugs. CBI’s Expanded Access Programs is dedicated to the nuances and intricacies of designing and implementing early access programs. Show More Summary
CBI’s 12th Life Sciences Trade and Channel StrategiesDecember 13-14, 2016 | Philadelphia, PAwww.cbinet.com/tradeDon’t miss the must-attend event for industry trade, channel, account and pharmacy strategy professionals!CBI’s Annual Trade...Show More Summary
PLOS Medicine and PLOS NTDs reflect on 15 years of World Toilet Day and announce the WASH Collection. UN World Toilet Day highlights the urgent need to address a global sanitation crisis by providing toilets
In Latest CMS Forecast Shows Big Drug Spending Growth Through 2025, I examined the July 2016 drug spending forecasts from the Centers for Medicare & Medicaid Services (CMS). Alas, last week’s election exploded these projections. Today, I analyze CMS’s official pre-election insights about payment for outpatient prescriptions drugs in 2025. Show More Summary
PLOS NTDs co-Editor in Chief Peter Hotez encourages US President-Elect Donald Trump to support pro-vaccine policies to protect public health. The 2016 US Presidential debates and campaign were mostly devoid of any meaningful science policy discussions. Beyond climate
ICYMI, the Roche Group recently made a startling disclosure: For the first half of 2016, the 340B Drug Pricing Program accounted for 18% of Genentech’s volume. I estimate that at that rate, hospitals and other 340B-covered entities claimed discounts on about $3.4 billion in purchases annually from Genentech. Show More Summary
I started writing about the drug industry – specifically the commercial side of the industry – in 2002 with the publication of the first issue of Pharma Marketing News. At the dawn of the social media age in 2005, I started writing Pharma...Show More Summary
Specialty Therapies 2017January 26-27, 2017 | Las Vegas, NVHead to Las Vegas this January to share and learn strategies for managing the high cost of specialty therapies management. Through thought-provoking sessions, panels and keynotes,...Show More Summary
Venomous snakes are widely dispersed across the globe, occupying a range of habits in both terrestrial and marine environments. A major part of venomous snakes’ predatory success is the venom proteins, which cause rapid cardiovascul...